One thing that is known about the placebo effect is that it involves several brain systems, each under the control of a particular type of messenger molecule, called a neurotransmitter. These systems, like everything else in the body, are regulated by genes. This has led some researchers to ask whether different versions of the genes in question might modulate a person’s susceptibility to placebos. Kathryn Hall, research fellow in medicine Beth Israel Deaconess Medical Center, led the research.
Trending News
Research Provides Clues to Spleen’s Role in Coronary Artery Disease
Genetic variants may drive visible changes in the spleen that contribute to heart disease
Patient Who Received Pig Kidney Becomes First To Progress to Human Kidney Transplant
Study shows xenotransplantation can serve as a bridge for patients with end-stage kidney disease
Pilots, Flight Attendants Have Greater Risk of Radiation-Related Cancer Death Than Other Professions
Findings support efforts to protect U.S. aircrews from cosmic radiation exposure